Publications
-
Is it Sufficient to Claim an Antibody only by Describing its Antigen?
- November 5, 2018
- Posted by: admin
- Category: Publications
No Commentswindow.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'UA-129164529-2'); EAGLE ALERTS Is it Sufficient to Claim an Antibody only by Describing its Antigen? November 2018 Things may be brewing with respect to antibody inventions. Just how much description is sufficient? After losing in the Federal Circuit, Amgen has decided to ask the -
Foreign companies transferring IP out of China: things to know
- October 30, 2018
- Posted by: admin
- Category: Publications
window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'UA-129164529-2'); China IP Developments in Biotech / Pharma Foreign companies transferring IP out of China: things to know October 2018 Inventions made in China Most foreign companies with R&D sites in China are aware of the fact that inventors having inventions made in China -
Prior Art Will Be Easier to Find due to creation of a new Prior Art Archive by Google, Cisco, MIT, and USPTO
- October 10, 2018
- Posted by: admin
- Category: Publications
window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'UA-129164529-2'); October 2018 IT giant Google and others are partnering with USPTO to bring us a new prior art archive. What is it? How is it going to affect us? Prior Art Will Be Easier to Find due to creation of a new Prior